FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000752627> ?p ?o ?g. }

• W2000752627 endingPage "7452" @default.
• W2000752627 startingPage "7452" @default.
• W2000752627 abstract "To investigate and compare the inhibitory effects of rapamycin in the different stages of liver fibrosis.We performed bile duct ligation (BDL) in male Wistar rats (n = 24). The experimental rats were classified into four groups: the BDL(+)/Rapa(-) group (un-treated control, n = 4), the BDL(+)/Rapa(+) group (treated 14 d after BDL, n = 8), the BDL(+)/Rapa(++) group (treated on the day after BDL, n = 8), and the BDL(-)/Rapa(-) group (un-treated, sham -operated control, n = 4). The BDL(+)/Rapa(+) and BDL(+)/Rapa(++) groups were administered rapamycin (2 mg/kg) for 28 d. The liver tissues were tested by immunohistochemical staining for α-smooth muscle actin (α-SMA) and cytokeratin.The liver mRNA levels of transforming growth factor (TGF)-β1 and platelet-derived growth factor (PDGF) were measured using the polymerase chain reaction. The protein levels of liver p70s6K and p-p70s6k were determined using Western blotting. α-SMA expression was lowest in the BDL(+)/Rapa(++)group. TGF-β1 and PDGF expression levels in the rapamycin-treated group were lower than those in the un-treated group and higher than those in the control groups (TGF-β1: 0.23 ± 0.00 vs 0.34 ± 0.01, 0.23 ± 0.0 vs 0.09 ± 0.00, P < 0.0001; PDGF: 0.21 ± 0.00 vs 0.34 ± 0.01, 0.21 ± 0.0 vs 0.09 ± 0.00, P < 0.0001). The p70s6k and p-p70s6k levels decreased in the treated groups and were lowest in the BDL(+)/Rapa(++)group (p70s6k: 1.05 ± 0.17 vs 1.30 ± 0.56, 0.40 ± 0.01 vs 1.30 ± 0.56, P < 0.0001; p-p70s6k: 1.40 ± 0.5 vs 1.67 ± 0.12, 0.70 ± 0.01 vs 1.67 ± 0.12, P < 0.0001).The results of our study indicate that rapamycin has inhibitory effects on liver fibrosis, and the treatment is most effective in the early stages of fibrosis." @default.
• W2000752627 created "2016-06-24" @default.
• W2000752627 creator A5010391034 @default.
• W2000752627 creator A5014583342 @default.
• W2000752627 creator A5016809746 @default.
• W2000752627 creator A5023457870 @default.
• W2000752627 creator A5038653113 @default.
• W2000752627 creator A5048549386 @default.
• W2000752627 creator A5052777579 @default.
• W2000752627 date "2014-01-01" @default.
• W2000752627 modified "2023-10-17" @default.
• W2000752627 title "Inhibitory effects of rapamycin on the different stages of hepatic fibrosis" @default.
• W2000752627 cites W126075184 @default.
• W2000752627 cites W1480905447 @default.
• W2000752627 cites W1520608174 @default.
• W2000752627 cites W1650596822 @default.
• W2000752627 cites W1918588012 @default.
• W2000752627 cites W1971636850 @default.
• W2000752627 cites W1976439025 @default.
• W2000752627 cites W1980940261 @default.
• W2000752627 cites W1983062597 @default.
• W2000752627 cites W1995700570 @default.
• W2000752627 cites W2002583299 @default.
• W2000752627 cites W2006874274 @default.
• W2000752627 cites W2015174638 @default.
• W2000752627 cites W2035099750 @default.
• W2000752627 cites W2038198293 @default.
• W2000752627 cites W2046159428 @default.
• W2000752627 cites W2046576895 @default.
• W2000752627 cites W2050585969 @default.
• W2000752627 cites W2055424385 @default.
• W2000752627 cites W2058780407 @default.
• W2000752627 cites W2070131943 @default.
• W2000752627 cites W2080391155 @default.
• W2000752627 cites W2082279739 @default.
• W2000752627 cites W2083630382 @default.
• W2000752627 cites W2089149502 @default.
• W2000752627 cites W2090142548 @default.
• W2000752627 cites W2091393830 @default.
• W2000752627 cites W2104193042 @default.
• W2000752627 cites W2122081319 @default.
• W2000752627 cites W2143937346 @default.
• W2000752627 cites W2154271188 @default.
• W2000752627 cites W2155815716 @default.
• W2000752627 cites W2157715481 @default.
• W2000752627 cites W2158129157 @default.
• W2000752627 cites W2292523598 @default.
• W2000752627 cites W2335187016 @default.
• W2000752627 doi "https://doi.org/10.3748/wjg.v20.i23.7452" @default.
• W2000752627 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4064090" @default.
• W2000752627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24966615" @default.
• W2000752627 hasPublicationYear "2014" @default.
• W2000752627 type Work @default.
• W2000752627 sameAs 2000752627 @default.
• W2000752627 citedByCount "14" @default.
• W2000752627 countsByYear W20007526272014 @default.
• W2000752627 countsByYear W20007526272015 @default.
• W2000752627 countsByYear W20007526272016 @default.
• W2000752627 countsByYear W20007526272017 @default.
• W2000752627 countsByYear W20007526272018 @default.
• W2000752627 countsByYear W20007526272021 @default.
• W2000752627 countsByYear W20007526272023 @default.
• W2000752627 crossrefType "journal-article" @default.
• W2000752627 hasAuthorship W2000752627A5010391034 @default.
• W2000752627 hasAuthorship W2000752627A5014583342 @default.
• W2000752627 hasAuthorship W2000752627A5016809746 @default.
• W2000752627 hasAuthorship W2000752627A5023457870 @default.
• W2000752627 hasAuthorship W2000752627A5038653113 @default.
• W2000752627 hasAuthorship W2000752627A5048549386 @default.
• W2000752627 hasAuthorship W2000752627A5052777579 @default.
• W2000752627 hasBestOaLocation W20007526271 @default.
• W2000752627 hasConcept C104317684 @default.
• W2000752627 hasConcept C118131993 @default.
• W2000752627 hasConcept C126322002 @default.
• W2000752627 hasConcept C134018914 @default.
• W2000752627 hasConcept C170493617 @default.
• W2000752627 hasConcept C180361614 @default.
• W2000752627 hasConcept C204232928 @default.
• W2000752627 hasConcept C2775960820 @default.
• W2000752627 hasConcept C2781294074 @default.
• W2000752627 hasConcept C55493867 @default.
• W2000752627 hasConcept C71924100 @default.
• W2000752627 hasConcept C85265743 @default.
• W2000752627 hasConcept C86803240 @default.
• W2000752627 hasConceptScore W2000752627C104317684 @default.
• W2000752627 hasConceptScore W2000752627C118131993 @default.
• W2000752627 hasConceptScore W2000752627C126322002 @default.
• W2000752627 hasConceptScore W2000752627C134018914 @default.
• W2000752627 hasConceptScore W2000752627C170493617 @default.
• W2000752627 hasConceptScore W2000752627C180361614 @default.
• W2000752627 hasConceptScore W2000752627C204232928 @default.
• W2000752627 hasConceptScore W2000752627C2775960820 @default.
• W2000752627 hasConceptScore W2000752627C2781294074 @default.
• W2000752627 hasConceptScore W2000752627C55493867 @default.
• W2000752627 hasConceptScore W2000752627C71924100 @default.
• W2000752627 hasConceptScore W2000752627C85265743 @default.
• W2000752627 hasConceptScore W2000752627C86803240 @default.
• W2000752627 hasIssue "23" @default.

• next